5JA1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sprint Bioscience AB

Watchlist Manager

Watchlist

Price: 0.336 EUR 10.89%

Market Cap: €67.8m

S	Sprint Bioscience AB XMUN:5JA1	SE
	Gunma Bank Ltd F:5F0	JP
C	Cabot Corp F:CBT	US
I	Impala Platinum Holdings Ltd XBER:IPHB	ZA
R	Relevium Technologies Inc F:6BX	CA

Profitability Summary

Sprint Bioscience AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Negative 3Y Average Gross Margin

-3 865%

Gross Margin is Increasing

-31 134% > 92%

Exceptional Operating Margin

58%

Negative 3Y Average Operating Margin

-20 025%

Operating Margin is Increasing

-154 361% > 58%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-19 898%

Net Margin is Increasing

-153 287% > 55%

Exceptional Free Cash Flow Margin

50%

Negative 3Y Average Free Cash Flow Margin

-16 447%

Free Cash Flow Margin is Increasing

-125 371% > 50%

Exceptional ROE

143%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-217%

ROIC is Increasing

-1 282% > 1 140%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.